ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,474,910 | +3334.9% | 902,095 | +3229.3% | 0.01% | – |
| Q2 2023 | $537,864 | +16.1% | 27,096 | +0.2% | 0.00% | – |
| Q1 2023 | $463,157 | +73.5% | 27,030 | +98.0% | 0.00% | – |
| Q4 2022 | $266,930 | -23.3% | 13,650 | -14.5% | 0.00% | – |
| Q4 2021 | $348,000 | -99.1% | 15,957 | -98.7% | 0.00% | -100.0% |
| Q3 2021 | $36,751,000 | -32.8% | 1,229,498 | -0.5% | 0.02% | -30.4% |
| Q2 2021 | $54,721,000 | -0.6% | 1,235,489 | -0.5% | 0.02% | -8.0% |
| Q1 2021 | $55,077,000 | -21.4% | 1,241,316 | -2.8% | 0.02% | -24.2% |
| Q4 2020 | $70,043,000 | +3815.2% | 1,277,310 | +1532.0% | 0.03% | +3200.0% |
| Q3 2020 | $1,789,000 | +16.3% | 78,267 | +6.4% | 0.00% | 0.0% |
| Q2 2020 | $1,538,000 | +62.2% | 73,569 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $948,000 | – | 67,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |